TNFSF10 and cancer: Moreover, intratumoral delivery of a TRAIL-expressing OAd has been found to increase the production of IFN-γ and other cytokines acting as maturation signals for DCs as a therapeutic benefit of engaging DCs activity in cancer virotherapy [39].